Cashu
Allergan Aesthetics Launches Innovative TrenibotE at AAD Meeting, Addressing Patient Aesthetic Concerns
4 days ago
Stocks
Health Care
abbv
Abbvie
NYSE: ABBV
-6.14 (-2.86%)
208.84
USD
At close at Apr 03, 20:33 UTC
Overview
Loading chart...
Key Stats
Market Cap
369.10B
Dividend Yield
0.00%
P/E Ratio
87.34
EPS
2.41
Revenue
56.33B
Avg. Volume
6.66M
About
What does ABBV do?
AbbVie is a North Chicago-based biopharmaceutical company that develops and sells medicines across various therapeutic areas, employing 50,000 staff since its IPO in January 2013. Key products include Humira, Botox, and NX-13 for ulcerative colitis.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.